Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Shugan detoxification granules is a Traditional Chinese Medicine (TCM) formulation developed by Shenzhen Traditional Chinese Medicine Hospital for the treatment of chronic hepatitis B (CHB). The formulation is based on the TCM principles of tonifying the kidney (Bushen), soothing the liver (Shugan), and clearing toxins (Jiedu). It is specifically investigated for its potential to reduce viral markers, including HBsAg, HBeAg, and HBV-DNA levels, in chronic HBV carriers. In clinical research, it is often evaluated as part of an optimized TCM protocol, sometimes compared against other formulations such as Bushen Jianpi (spleen-strengthening) granules to determine the most effective strategy for managing inactive or low-replicative HBV carriers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Shugan detoxification granules.